The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Our new article outlines best practices for navigating an uncertain regulatory environment for mRNA-based products, and explores why partnering with a contract development and manufacturing organization (CDMO) can provide biotechnology and pharmaceutical companies with peace of mind when it comes to adhering to regulatory guidelines.
Specifically, the article covers the following topics:
- Current and developing regulatory guidance for mRNA products
- The importance of early engagement with regulatory bodies
- Choosing a strategic CDMO partner for mRNA development